In line with the data on a decreased function of PGC-1α in PD and on the therapeutic potential of its activation, there is a hope that transcriptional activation of mitochondrial biogenesis and antioxidant responses via PGC-1α activation may hold therapeutic value. The gene discussed is PPARGC1A; the disease is Parkinson disease.